# DESCRIPTION

## FIELD OF THE INVENTION

- introduce synergistic pharmaceutical composition

## BACKGROUND OF THE INVENTION

- describe cancer cell characteristics
- discuss prior art on apoptosis and cell cycle regulation

## OBJECTIVES OF THE INVENTION

- state objectives of the invention

## SUMMARY OF THE INVENTION

- summarize synergistic pharmaceutical composition

## DETAILED DESCRIPTION OF THE INVENTION

- describe extraction and purification of Litsea cubeba seed oil

### EXAMPLES

- isolate and characterize compounds C1, C2, C3, and C4 from Litsea cubeba seed oil
- demonstrate anti-cancer activity of compounds C1, C2, C3, and C4 individually and in combination
- show induction of apoptosis by combined vapor of compounds C2, C3, and C4
- demonstrate inhibition of cell cycle progression by combined vapor of compounds C2, C3, and C4
- show deactivation of Akt by combined vapor of compounds C2, C3, and C4
- demonstrate synergistic effect of combined vapor of compounds C2, C3, and C4 on lung cancer cells

### Materials and Methods

- describe cell culture conditions
- outline electrophoresis and immunoblotting procedures
- summarize various assays (Co-IP, Trypan Blue, MTT, JC1, AnnexinV-Cy3, Immunofluorescence

### Results

- describe bioactivity guided isolation and purification of oils
- summarize effects of CVp on cell death and apoptosis
- outline CVp-induced apoptosis in lung cancer cells
- describe impairment of cyclin D1 by CVp and inhibition of Akt phosphorylation

### Advantages of the Invention

- list advantages of the invention

